Recognised as one of the leading UK players in the healthcare investment market, Downing LLP is pleased to announce that it has been selected as a finalist in two upcoming prestigious industry awards: firstly, in the Private Equity Investor of the Year category in next week’s HealthInvestor Awards 2021 and secondly, in the Investor category in the LaingBuisson Awards 2021, that will be held in November 2021.
HealthInvestor Awards 2021
The HealthInvestor Awards promote excellence and recognise innovation in the independent healthcare sector. This year, the judges are looking for organisations and individuals that have made an outstanding contribution to healthcare between March 2020 – March 2021 in this competitive space that is becoming an increasingly important sector for the UK economy. The awards are aimed at those professionals investing in, advising or operating companies in the health and social care sector and the finalists represent the leading players in this diverse and burgeoning market.
Downing’s commitment to healthcare has continued to grow sustainably throughout 2020-21 against the backdrop of the Covid-19 pandemic, with 13 significant healthcare transactions completed benefitting numerous communities and individuals within the healthcare space.
LaingBuisson Awards 2021
Now in its 16th year, the LaingBuisson Awards celebrate businesses that set new standards of excellence throughout the healthcare sector.
Downing is actively investing right across the healthcare spectrum, including elderly residential healthcare, specialist care, specialist education, retirement living, health services, medical devices, imaging and diagnostic services, biotechnology and health & wellbeing platforms.
The final winner of the HealthInvestor Awards will be announced at an awards ceremony held on Monday 13th September and in November 2021 for the LaingBuisson Awards.
Commenting on both of Downing’s finalist nominations, Mark Gross, Partner at Downing LLP, said: "The importance of investment in the healthcare sector has been highlighted in the last year, more than ever, in the context of the global pandemic. It is Downing’s motivation to support growing companies in the healthcare sector that are typically underserved by other investors. In doing so, we are proud to provide a positive impact to numerous people who benefit from the amazing work that these companies do. We focus on a continued commitment to bettering society through our proactive ESG and sustainability agenda, which simultaneously puts us alongside motivated and innovative management teams and businesses while also driving strong risk adjusted returns for our investors.”
Downing wishes the best of luck to Mark and his team.
For more information, please visit https://www.downing.co.uk/business/development-capital